ArticleJournal of personalized medicine2022

Discovering Tuberosin and Villosol as Potent and Selective Inhibitors of AKT1 for Therapeutic Targeting of Oral Squamous Cell Carcinoma.

Mohd Adnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.